GSK Plc’s upcoming dividend of £0.14 per share at 4.4% yield payment date is 12 October 2023 and eligible shareholders of GSK shares must buy the share before 17 August 2023. The GSK Plc payout ratio is comfortable at 42% and the cash payout ratio is 99%.
GSK share has performed well in the last month, increasing by 3.82% but plummeting by 8.60% in the last six months. GSK Plc (LON: GSK) share has a negative year-to-date return of 8.60% and a negative one-year return of 3.59%. The average volume is 5.194 Million and the current volume is 4.876 Million where the current volume is below the average volume.
Moreover, GSK Plc (GSK) share market capitalization is $56.492 Billion and the total revenue is $29.324 Billion. Moreover, the share’s basic EPS is $3.6 and the price-to-earnings ratio is 3.8. GSK has a debt-to-equity ratio of 116.6%, as reported by Simply Wall St. This implies it has more debt than equity, which is the difference between its total assets of $59.46 Billion and total liabilities of $47.30 Billion. GSK debt is $21.47 Billion, while its equity is $12.16 Billion.
Technical Analysis of GSK Share Price in 1-D Timeframe
The price action shows that GSK Plc (LON: GSK) share price has been on a declining trend for the last six months, that the last six months the trend was downward and decreased by 8.60% by making lower highs and higher lows.
At the time of publishing the GSK share price is trading at $13.710 and facing resistance from the trendline over the one-day time frame and highlighting a narrower range.
On further observation of GSK share, the sellers were dominating and made multiple new swing lows. After reaching a low of $1302.6, sellers’ dominance decreased and sellers failed to make another new swing low as the buyers increased and the swing low shifted upwards. On this price action, a symmetrical triangle might be in formation.
Therefore, if it maintains the current level, the GSK prices could continue to move upward and reach the first and second resistances of $14.116 and $14.430.
However, if the GSK price fails to sustain the current level and drops, it might hit the nearest support levels of $13.312 and $12.998.
At the time of publishing, GSK Plc is trading below the 50, 100, and 200-day EMA (exponential moving averages), which rejects the GSK price trend.
However, the 20-day EMA supports the trend. If more buying volume adds up, then the price might conquer, rejecting EMAs by making higher highs and lows.
Hence, the GSK price is expected to move upwards showing a bullish overview over the daily time frame chart.
The current value of RSI is 50.41 points. The 14 SMA is at the median line at 50.41 points which indicates that GSK share is in a neutral state and both lines have intermingled multiple times, indicating the consolidation to bullishness for GSK stock.
The MACD line at 0.0101 and signal line at 0.0011 are above the zero line and both lines have crossed each other. A bullish crossover is observed with a small gap between the lines in the MACD oscillator which signals consolidation to bullishness for the Gsk stock price.
Summary
GSK Plc indicates that the investors and traders of the share price are consolidating to bullishness on the 1-D time frame. The price action reflects a bullish outlook at the time of publishing. The technical analysis tools of GSK stock price also support consolidation to bullishness. The MACD, RSI, and EMA highlight positive signals and imply that an uptrend is anticipated in GSK share price.
Technical Levels
- Support levels: The nearest support levels for Gsk share price are $13.312 and $12.998.
- Resistance levels: The nearest resistance levels for the Gsk share price are $14.116 and $14.430.
Disclaimer
In this article, the views and opinions stated by the author, or any people named are for informational purposes only, and they don’t establish the investment, financial, or any other advice. Trading or investing in cryptocurrency assets comes with a risk of financial loss.
Steve Anderson is an Australian crypto enthusiast. He is a specialist in management and trading for over 5 years. Steve has worked as a crypto trader, he loves learning about decentralisation, understanding the true potential of the blockchain.
Source: https://www.thecoinrepublic.com/2023/08/12/gsk-share-price-forecast-can-4-dividend-attract-more-investors/